Sort by
Refine Your Search
-
Listed
-
Employer
- FUNDACIÓN PARA LA INVESTIGACIÓN MÉDICA APLICADA
- +Pec Proteomics Research Group
- Basque Center for Applied Mathematics
- CIC biomaGUNE
- CSIC
- Catalan Institute of Nanoscience and Nanotechnology (ICN2)
- Center for Biological Research "Margarita Salas"-CSIC
- Centro de Biotecnología y Genómica de Plantas, CBGP (UPM-INIA)
- FUNDACION INSTITUTO INVESTIGACION SANITARIA FUNDACION JIMENEZ DIAZ
- ICN2
- IMDEA Networks Institute
- IRB Barcelona
- Indra Deimos
- Institut Català de Nanociència i Nanotecnologia
- Institut de Recerca Biomèdica de Lleida, Fundació Dr. Pifarré (IRBLleida)
- Universidade de Vigo
- Universitat de Lleida
- University of Seville
- University of Valencia
- noma de Barcelona
- 10 more »
- « less
-
Field
-
-represented backgrounds. The objective of the research project is to perform Bayesian inversion to characterise the velocity field of 3D partial differential equations describing brain fluid and solute movement
-
molecular sensing. The project also involves studying drug-target interactions with non-canonical DNA structures, leveraging advanced techniques like fluorescence spectroscopy, mass spectrometry, TEM, and NMR
-
: biocompatible nanovectors with therapeutic potential for the targeted delivery of bioactive molecules in personalized medicine, and active contributors to disease mechanisms and sources of diagnostic
-
from the multistatic system. - Participate in the development of Automatic Target Recognition (ATR) algorithms and methods for identifying dielectric properties. - Contribute to the technical
-
therapeutic targets for the disease. Cell cultures and molecular biology techniques will be used to study the underlying mechanisms. The project will be carried out in a hospital setting using human samples
-
TDP-43 aggregation, decrease stress granules, block exportins avoiding the transport to the cytoplasm, etc. The great challenge is the recovery of TDP-43 homeostasis. In that case, a multi-target
-
Universidad de Navarra, we seek to understand the molecular basis underlying the aberrant hematopoietic differentiation that takes place in MDS and AML, with the ultimate goal of finding new therapeutic targets
-
Institut de Recerca Biomèdica de Lleida, Fundació Dr. Pifarré (IRBLleida) | Spain | about 2 months ago
target for premature vascular aging in chronic kidney disease and type 2 diabetes" and will perform the following tasks: -Models of vascular calcification in experimental animals. -Study of
-
months. You will participate in international conferences and secondments to other organisations within the SLICE network and in outreach activities targeted at a wide audience. A competitive salary
-
of generating a certain type of organ/cell type. In this way the target organ is formed exclusively from the microinjected stem cells. The group works with mouse and rat embryonic stem cells and human iPS cells